U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528781) titled 'Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant Volume' on March 24.
Brief Summary: The goal of this observational study is demonstrate that a novel artificial intelligence based software for the quantification of the mitral regurgitation on 3-dimensional transesophageal echocardiography (3D CFQ) is more reproducible and accurate than the conventional assessment of mitral regurgitation performed with 2-dimensional echocardiography. The main question aims to answer is to demonstrate the agreement between 3D-CFQ measurement of the mitral regurgitant volume and the cardiac magnetic resonance measurement of t...